Skip to content
Medical Health Aged Care

2024 Federal Budget should fund GP research for better health

Royal Australian College of GPs 2 mins read

The Royal Australian College of GPs (RACGP) is calling on the Federal Government to invest in general practice-based research to improve the evidence base for GPs caring for patients and helping people live healthier.  

Australia’s largest peak GP body, the RACGP is calling for funding and support to establish a national practice-based research network in its pre-Budget submission 2024-25 

GPs are strongly in support of the measure which would improve patient care. A nationwide newsGP poll found the greatest benefits of a national practice-based research network would be: 

  • stronger evidence for clinical decisions 68% 

  • More career opportunities for GPs within general practice 13% 

  • better information to provide patients 11%  

RACGP President Dr Nicole Higgins said: “Funding homegrown health research carried out in the place where most people access healthcare will improve the health and wellbeing of Australians. It’s simple. 

“We know that practice-based health research networks are immensely valuable. The Canadian network produces strong evidence that results in better care for the health issues the country is grappling with, including chronic disease, ageing, addiction and even allergies. 

“And when the pandemic struck, the United Kingdom used its network to rapidly establish a large-scale trial of COVID treatment in general practice. 

“The pandemic exposed a gap in Australia’s health system; a major underinvestment in general practice-based research. We don’t have a national network like the UK or Canada, so we couldn’t run large-scale trials of COVID treatment in general practice. 

“If we had a national network in Australia, we would be much better prepared for the next pandemic, have much needed data on GP consultations, and GPs would be better equipped with solid evidence to tackle the health challenges of today and the future.  

“We do have smaller practice-based research networks in Australia that show the value of homegrown research, such as the Translating Research Outcomes in the Primary Health Interface (TROPHI) project, in outer eastern Melbourne. This innovative project is focused on improving care in line with local community needs – developing better tools and support for people with mental health concerns, is just one example. It is a collaboration between the RACGP, the University of Melbourne and Monash University, with seed funding from the Windermere Foundation.   

“I urge the government to make this investment in the next Budget – it will pay dividends in terms of improving our health and wellbeing for generations to come.”  

~ENDS


About us:

The Royal Australian College of General Practitioners (RACGP) is the peak representative organisation for general practice, the backbone of Australia’s health system. We set the standards for general practice, facilitate lifelong learning for GPs, connect the general practice community, and advocate for better health and wellbeing for all Australians.

Visit www.racgp.org.au. To unsubscribe from RACGP media releases, click here.


Contact details:

John Ronan
Media Adviser

Ally Francis
Media Adviser

Stuart Winthrope
Media Officer

Contact: 03 8699 0992media@racgp.org.au

Follow us on Twitter: @RACGP and Facebook.

More from this category

  • Medical Health Aged Care
  • 31/10/2024
  • 17:55
Kyowa Kirin Co., Ltd.

Kyowa Kirin Announces Changes in Top Leadership Positions to Strengthen Operations as a Global Specialty Pharmaceutical Company

Masashi Miyamoto to be named Chairman and CEO Abdul Mullick to be named President and COO Changes designed to further deliver on company’s 2030…

  • Contains:
  • Medical Health Aged Care
  • 31/10/2024
  • 12:10
MannKind

First Site Initiated in Australia for MannKind’s Phase 3 Clinical Trial Evaluating Clofazimine Inhalation Suspension for the Treatment of Nontuberculous Mycobacterial (NTM) Lung Disease

ICoN-1 study presentation planned November 1 at NTM Symposium AustraliaStudy is cleared by health authorities to proceed in Australia, U.S., Japan and South Korea, with Taiwan anticipated by end of year DANBURY, Conn., Oct. 30, 2024 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of innovative inhaled therapeutic products and devices for patients with endocrine and orphan lung diseases, announced today that it has initiated its first site for its Phase 3 clinical trial evaluating efficacy and safety of Clofazimine Inhalation Suspension for the treatment of nontuberculous mycobacterial (NTM) lung disease. The study,…

  • Business Company News, Medical Health Aged Care
  • 31/10/2024
  • 11:03
Firebrick Pharma

Agreement Signed to Market Nasodine to Healthcare Professionals in Singapore

Firebrick Pharmais pleased to announce that it has executed a Marketing Representation Agreement (the “Agreement”) with Singapore-based, Innorini, trading as Innorini Life Sciences (“Innorini”). The initial term of the Agreement is one year with the option to renew for subsequent one-year terms by mutual agreement. Under the Agreement, Innorini will undertake “Marketing Services” commencing 1 November 2024. The Marketing Services comprise sampling and promotion of Nasodine® Nasal Spray (“Nasodine”) to General Practitioners (“GPs”) and hospital-based doctors and pharmacists (collectively “HCPs”) in Singapore. In addition to building awareness and support of Nasodine by HCPs, Innorini will be expected to sell Nasodine…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.